1. Deng, Ling, Liao, Li, Zhang, Yin-Ling, Shao, Zhi-Ming, Li, Da-Qiang. 2024. SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1. In Science advances, 10, eadj4009. doi:10.1126/sciadv.adj4009. https://pubmed.ncbi.nlm.nih.gov/38569025/
2. Huang, Qingxia, Yao, Yao, Wang, Yisa, Zhao, Daqing, Li, Xiangyan. 2023. Ginsenoside Rb2 inhibits p300-mediated SF3A2 acetylation at lysine 10 to promote Fscn1 alternative splicing against myocardial ischemic/reperfusion injury. In Journal of advanced research, 65, 365-379. doi:10.1016/j.jare.2023.12.012. https://pubmed.ncbi.nlm.nih.gov/38101749/
3. Tian, Yuan, Das, Debatosh, Li, Min, Yang, Jingfang, Liu, Yinggao. 2023. Phylogenetic Analysis of Spliceosome SF3a2 in Different Plant Species. In International journal of molecular sciences, 24, . doi:10.3390/ijms24065232. https://pubmed.ncbi.nlm.nih.gov/36982311/
4. Duan, Yifei, Kang, Liyuan, He, Yujie, Wen, Zhining, Chen, Lei. 2023. A pilot study on identifying gene signatures as markers for predicting patient response to antiseizure medications. In Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 44, 2137-2148. doi:10.1007/s10072-023-06605-2. https://pubmed.ncbi.nlm.nih.gov/36658410/
5. Pellacani, Claudia, Bucciarelli, Elisabetta, Renda, Fioranna, Gatti, Maurizio, Somma, Maria Patrizia. 2018. Splicing factors Sf3A2 and Prp31 have direct roles in mitotic chromosome segregation. In eLife, 7, . doi:10.7554/eLife.40325. https://pubmed.ncbi.nlm.nih.gov/30475206/
6. Chen, Chaoqun, Huang, Fang, Li, Xiaojie, Qi, Yangfan, Wang, Yang. 2024. Identification of splicing factors signature predicting prognosis risk and the mechanistic roles of novel oncogenes in HNSCC. In Biochimica et biophysica acta. Molecular basis of disease, 1870, 167115. doi:10.1016/j.bbadis.2024.167115. https://pubmed.ncbi.nlm.nih.gov/38458543/
智鼠故事 
